Atopic dermatitis
Conditions
Interventions
None listed
Sponsors
Mie National Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Patients with atopic dermatitis aged 4 to 15 years (2) Patients with EASI score of 16 or higher (3) Patients judged by physicians to be eligible for novel systemic therapy (4) Patients and caregivers who provided written informed consent
Exclusion criteria
Exclusion criteria: (1) Patients receiving or scheduled to receive biologics or JAK inhibitors for conditions other than atopic dermatitis (chronic spontaneous urticaria, seasonal allergic rhinitis, eosinophilic granulomatosis with polyangiitis, bronchial asthma, chronic rhinosinusitis with nasal polyps, prurigo nodularis) (2) Patients receiving or scheduled to receive immunosuppressants other than novel systemic therapies (oral corticosteroids, cyclosporine, etc.) (3) Patients with serious underlying diseases other than allergic diseases at enrollment (4) Patients who have already started novel systemic therapy (5) Patients judged inappropriate for participation by the principal investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Caregiver work productivity (WPAI-AD-CG), health-related quality of life (patients: EQ-5D-Y-3L, caregivers: EQ-5D-5L), healthcare costs (direct and indirect costs) | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical improvement of atopic dermatitis (EASI, POEM, NRS), quality of life improvement (patients: CDLQI, caregivers: DFI) | — |
Countries
Japan
Contacts
Public ContactYu Kuwabara
Mie National Hospital Allergy Center
Outcome results
None listed